Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma: pathogenic factors and current management.

R Penny

    Australian and New Zealand Journal of Medicine
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mechanisms of programmed cell death associated to severe dengue in human renal lesions.

    Microbial pathogenesis·2024
    Same author

    Z-scan studies of the nonlinear optical properties of gold nanoparticles prepared by electron beam deposition.

    Applied optics·2016
    Same author

    Cell-mediated immune deficiency in Hodgkin's disease.

    Immunology today·2014
    Same author

    Clinical immunology in Australia.

    Immunology today·2014
    Same author

    Mobile phones, heat shock proteins and cancer.

    Differentiation; research in biological diversity·2001
    Same author

    Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension.

    Circulation·2000
    Same journal

    Gastroenterological Society of Australia, Annual Scientific Meeting, May 1980.

    Australian and New Zealand journal of medicine·2020
    Same journal

    'A touch of sugar'--a dangerous euphemism still alive and well.

    Australian and New Zealand journal of medicine·2001
    Same journal

    Silent myocardial ischaemia following methysergide overdose.

    Australian and New Zealand journal of medicine·2001
    Same journal

    Extensive jugular and upper limb thrombosis in a patient with factor V Leiden mutation and non-Hodgkin's lymphoma.

    Australian and New Zealand journal of medicine·2001
    Same journal

    Visual loss as the presenting feature of giant cell arteritis.

    Australian and New Zealand journal of medicine·2001
    Same journal

    Lymphoproliferative disease causing angioedema--an uncommon association.

    Australian and New Zealand journal of medicine·2001
    See all related articles

    The causes of scleroderma are unknown, but may involve blood vessel, collagen, or immune system issues. Current treatments offer limited relief for distressing symptoms.

    Area of Science:

    • Rheumatology
    • Immunology
    • Vascular Biology

    Background:

    • Scleroderma's etiology is currently unknown.
    • Pathogenesis may involve vascular, collagen, or immune system abnormalities.

    Purpose of the Study:

    • To review the potential pathogenetic mechanisms of scleroderma.
    • To discuss current management strategies and their effectiveness.

    Main Methods:

    • Literature review of studies on scleroderma etiology and pathogenesis.
    • Analysis of current treatment approaches for symptom management.

    Main Results:

    • Etiology of scleroderma remains undetermined.
    • Potential pathogenetic pathways include vascular, collagen, and immune system dysregulation.

    Related Experiment Videos

  • Current management, while often unsatisfactory, can alleviate some symptoms.

    • Conclusions:

    • Further research is needed to elucidate the unknown etiology of scleroderma.
    • Understanding pathogenetic mechanisms is crucial for developing effective therapies.
    • Symptomatic relief is achievable with current management, despite limitations.